Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07144761 · ClinicalTrials.gov registry record · NA

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

A NA study of Blepharoplasty, sponsored by Osheru.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
5
Study locations

NCT07144761 is a NA study of Blepharoplasty that is actively recruiting participants, run by Osheru. The registered enrollment target is 200 participants. The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07144761, a NA study of Blepharoplasty, is actively recruiting participants, sponsored by Osheru.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
5
Study locations

Study Summary

The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.

Conditions Studied

Interventions

  • DEVICE Ziplyft

Study Locations (5)

Florida

  • Center for Excellence in Eye Care - Miami

Minnesota

  • Vance Thompson Vision - Alexandria

Pennsylvania

  • Eye Care Specialists - Kingston

South Dakota

  • Vance Thompson Vision - Sioux Falls

Wisconsin

  • The Eye Centers of Racine and Kenosha, LTD - Kenosha

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-08
Est. Completion 2025-12
Phase NA

Sponsor

Osheru

2 total trials

What the Registry Record Tells You About NCT07144761

The ClinicalTrials.gov registry entry for NCT07144761 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Osheru, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blepharoplasty appearing as the primary indexed condition, and to 1 intervention - of which Ziplyft is the first listed.

NCT07144761 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Minnesota, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07144761 about?

NCT07144761 is a clinical study titled "Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™". The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.

What is the current status of trial NCT07144761?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-08. Estimated completion is 2025-12.

What conditions does trial NCT07144761 study?

This clinical trial studies the following conditions: Blepharoplasty.

What interventions are being tested in trial NCT07144761?

The interventions under investigation include: Ziplyft (DEVICE).

Who is sponsoring clinical trial NCT07144761?

This trial is sponsored by Osheru, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07144761 being conducted?

This trial has 5 study locations across Florida, Minnesota, Pennsylvania, South Dakota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blepharoplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.